Time To Take Profits On Gilead Sciences (Rating Downgrade)
Source: SeekingAlpha
2026-02-20 14:24:17 ET
Shares of Gilead Sciences, Inc. ( GILD ), my favorite in the HIV drugs market, have risen 23.3% since my previous article , " Gilead Sciences: From All-Time Highs To Higher Highs. "...
Read the full article on Seeking Alpha
For further details see:
Time To Take Profits On Gilead Sciences (Rating Downgrade)
Ipsen ADR
NASDAQ: IPSEY
IPSEY Trading
0.0% G/L:
$46.31 Last:
4,394 Volume:
$46.31 Open:
IPSEY Latest News
December 07, 2025 05:33:00 pm
ImCheck Reports Durable Responses and Early Overall Survival Signal with ICT01 in First-line AML at ASH 2025
December 05, 2025 05:00:00 am
ImCheck Announces Oral Presentation of ICT01 First-Line AML Data at the 67th ASH Annual Meeting
June 02, 2025 08:00:00 am
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
